Related Experiment Video
Updated: Aug 14, 2026
16:23
Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
Published on: February 26, 2014
Age-dependent disposition of amobarbital: analog computer evaluation
Journal of the American Geriatrics Society
|December 1, 1978
Summary
Elderly individuals experience a longer amobarbital half-life due to slower metabolism. Reducing nightly doses for seniors is crucial to maintain safe amobarbital blood levels.
Area of Science:
- Pharmacokinetics
- Geriatric Pharmacology
- Drug Metabolism
Background:
- Amobarbital pharmacokinetics vary with age.
- Understanding age-related changes in drug metabolism is vital for safe dosing.
Purpose of the Study:
- To analyze amobarbital blood levels in young and elderly subjects.
- To determine age-related differences in amobarbital absorption, distribution, and metabolism.
- To provide dosing recommendations for elderly patients.
Main Methods:
- Analysis of previously published amobarbital blood level data.
- Utilized an analog computer for pharmacokinetic modeling.
- Incorporated literature data for rate constants of drug processes.
Main Results:
- Volume of distribution for amobarbital remained consistent across age groups.
- Biologic half-life significantly increased in elderly subjects (86.62 hours) compared to younger subjects (22.8 hours).
- Decreased amobarbital metabolism rate was identified as the primary cause for the prolonged half-life in the elderly.
Conclusions:
- Age-related decrease in amobarbital metabolism significantly impacts its elimination half-life.
- The one-point dosing method necessitates a substantial reduction in nightly amobarbital dosage for elderly patients.
- Recommended nightly amobarbital dose for elderly subjects should be reduced from 200 mg to 50 mg to achieve comparable steady-state blood levels in younger adults.
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...